17ohp Compounded denied as not medically necessary by Blue Cross Blue Shield?
Most insurers reverse a medical-necessity denial when the appeal cites the specific clinical guideline (NCCN, ADA, AACE, etc.) that supports the requested treatment for your indication.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for 17ohp compounded are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on 17ohp Compounded
## Why BCBS Denied This as Not Medically Necessary
A medical-necessity denial from Blue Cross Blue Shield means the insurer reviewed your claim and concluded that compounded 17-hydroxyprogesterone caproate does not meet its internal clinical criteria for coverage. BCBS's medical-necessity standard is defined in its coverage policy — not by your physician's judgment alone — and the denial letter must state which criteria were not met.
This type of denial is highly appealable. The insurer's criteria are typically drawn from FDA labeling and clinical-practice guidelines issued by professional obstetric organizations. If your prescriber documented your clinical picture thoroughly and their reasoning aligns with those guidelines, the evidence to reverse the denial is very likely already in your chart.
## Federal Appeal Rights
- ACA §2719 external review: You are entitled to an independent external review by an accredited IRO if internal appeal fails. File within the deadline stated in your denial notice — typically around four months from the denial date, though your plan document is the authoritative source.
- ERISA §503 (self-funded plans): Guarantees a full and fair internal review with written explanation of any denial.
- Expedited review: If a standard timeline would endanger your health, request expedited processing in writing — you can file expedited internal and external review at the same time.
## Concrete Appeal Steps
1. Read the denial letter carefully. Identify which specific medical-necessity criteria BCBS says you did not meet. 2. Obtain BCBS's published Coverage Medical Policy for this drug and read the stated coverage criteria in full. 3. Compare your chart documentation against each criterion. Flag any gap — then work with your prescriber to document anything that is present clinically but not yet recorded. 4. Submit an internal appeal within your plan's deadline (commonly 180 days from denial) with the full documentation package below. 5. If denied on internal appeal, immediately request external review.
## Documentation to Gather
- Diagnosis confirmation: Obstetric records that clearly establish the covered indication, including gestational history and relevant risk factors.
- Prior-treatment history: A chronological list of any other therapies considered or tried, with start/stop dates and outcomes, showing the clinical rationale for reaching this prescription.
- Clinical-severity documentation: Chart notes, laboratory or imaging results, and any specialist assessments that quantify the severity of the clinical problem.
- Prescriber medical-necessity letter: A detailed letter — signed and on letterhead — explaining why the clinical picture meets each criterion in BCBS's own policy. The letter should reference the applicable professional guideline organization (e.g., the relevant obstetric society) and connect each guideline element to a specific chart finding.
## Criteria-Mapping Structure
The most persuasive appeal packets use a direct-mapping format:
| BCBS Coverage Criterion | Chart/Clinical Evidence Meeting That Criterion | |---|---| | Copy each listed requirement verbatim from the BCBS policy | Corresponding chart note, date, prescriber statement | | Any step-therapy or prior-treatment requirement | Documented treatment history with dates and outcomes |
Obtain the current BCBS coverage policy directly — policies vary by affiliate and are updated periodically. Your prescriber's office can usually obtain this on your behalf.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied as not medically necessary of AAT Augmentation
- Blue Cross Blue Shield denied as not medically necessary of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied as not medically necessary of Anti Cd 20 Ocrevus
- Blue Cross Blue Shield denied as not medically necessary of Arni Entresto